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Several environmental (external) and genetic (internal) fac-
tors are involved in the development of diabetic retinopathy
(DR). Proper screening and early detection of such factors
shall improve the prevention and treatment of this blinding
disease. Lately, oxidative stress and factors influencing it
have been recognised as important determinants of DR
appearance and fulmination. Recently, beside genetical fac-
tors, epigenetic mechanisms (i.e., global acetylation of retinal
histone H3) have been demonstrated to play an important
role in the development and progression of DR to more
severe and vision threatening stages, proliferative diabetic
retinopathy and diabetic macular edema. Other internal
factors affecting DR determined by exome sequencing may
prove very helpful in the evaluation of diabetic retinopathy,
while screening for external factors may supplement pre-
vention or early diagnosis of the disease. Furthermore, new
treatment modalities in microvascular disorders such as DR
are emerging that may affect oxidative stress.
The articles contained in the present issue include both
reviews and basic scientific studies focused on characterizing
DR.
In the work by D. J. Eszes et al. entitled “Diabetic
Retinopathy ScreeningUsing Telemedicine Tools: Pilot Study
in Hungary,” the authors showed that telemedicine could
be a strong method, supporting eye care professionals and
allowing for faster and more comfortable DR screening.
Moreover, participants found digital retinal screening to
be reliable and comfortable. Thirty percent of the patients
had never participated in any ophthalmological screening.
From all patients examined, 25.7% had DR based upon a
standard fundus camera examination and a UK-based DR
grading protocol (SpectraTM software). Additionally, there
was a statistically significant relationship between economic
activity, education and marital status, and future interest of
participation. The study represents part of a larger Diabetic
Retinopathy Initiative supported by EURETINA in the pilot
city, Szeged, Hungary.
In the work by S. Vujosevic and E. Midena entitled
“Diabetic Retinopathy in Italy: Epidemiology Data and
Telemedicine Screening Programs,” the authors reviewed the
available epidemiological data onDR and telematic screening
realities in Italy. In Italy, the number of people living with
diabetes is about 3.5 million (5.5% of the population), with an
increase by about 60% in the last 20 years, and 1 person out
of 3 is older than 65 years. The Italian Health Service system
estimates that 10 billion euros are spent annually on caring
for patients with diabetes, a figure that increases yearly. At the
present time, the use of telemedicine for the screening of DR
in Italy is confined to geographically limited locations. They
concluded, however, that telemedicine might be helpful for
establishing a national screening program in Italy.
In the work by A. Horwitz et al. entitled “Danish Nation-
wide Data Reveal a Link between Diabetes Mellitus, Diabetic
Retinopathy, and Glaucoma,” the authors showed that the
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use of diabetic drugs was strongly associated with the use
of antiglaucomatous drugs, while the presence of DR and/or
joint complications with DR and nephropathy increases the
risk of glaucoma. Moreover, concomitant antihypertensive
medication was overall associated with an increased risk of
glaucoma.However, the combination of𝛽-blocker and renin-
angiotensin system inhibitors appeared to have a significantly
lower hazard ratio for glaucoma onset in subjects with
diabetes. They concluded that a strong association between
DM and treatment for glaucoma was shown in the entire
Danish population.
In the work by S. Vavuli et al. entitled “Elevated Lev-
els of Plasma IgA Autoantibodies against Oxidized LDL
Found in Proliferative Diabetic Retinopathy but Not in
Nonproliferative Retinopathy,” the authors showed that IgA
autoantibodies were increased in proliferative DR, especially
in Type 2 diabetes. The high levels of IgA reflect the inflam-
matory process and enlighten the role of oxLDL and its
autoantibodies in proliferative DR.
In the work by S. S. Pukl et al. entitled “Visual Acuity,
Retinal Sensitivity, and Macular Thickness Changes in Dia-
betic Patients without Diabetic Retinopathy after Cataract
Surgery,” the authors showed that underlying diabetes has
no effect upon the surgical outcome of cataract surgery
in patients with diabetes and having no DR. Best cor-
rected visual acuity (BCVA) measured by ETDRS letters
improved significantly and similarly in subjects with diabetes
in comparison to subjects without diabetes. However, slight
thickening of wider macula and corresponding decrease in
retinal sensitivity observed in patients with diabetes 6months
postoperatively might influence visual function on the long
term.
In the work by P. Romero-Aroca et al. entitled “Diabetic
Macular Edema Pathophysiology: Vasogenic versus Inflam-
matory,” the authors addressed the pathogenesis of diabetic
macular edema. In the paper they reviewed the data currently
available, focusing on vascular endothelial growth factor
(VEGF), angiogenesis, and inflammation.
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